• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

v-Ki-ras癌基因与γ干扰素在小鼠成纤维细胞组织相容性抗原表达调控中的相互作用。

Interaction of v-Ki-ras oncogene and interferon-gamma in the control of histocompatibility antigen expression in mouse fibroblasts.

作者信息

Morris A G, Ward G A, Bateman W J

机构信息

Department of Biological Sciences, University of Warwick, Coventry, United Kingdom.

出版信息

Cell Immunol. 1989 May;120(2):470-6. doi: 10.1016/0008-8749(89)90214-1.

DOI:10.1016/0008-8749(89)90214-1
PMID:2497992
Abstract

C3H10T1/2 fibroblasts when transformed with Kirsten murine sarcoma virus lose the ability to be induced to express class II major histocompatibility complex antigens when induced with interferon-gamma (IFN-gamma). Sublines were derived from transformed lines by cell sorting after treatment with IFN-gamma, sorting for low or high expression of H-2Ak. These sublines remained stably noninducible or inducible for class II antigen for several passages after sorting. In all other respects tested, viz, sensitivity to IFN-gamma for the generation of an antiviral state or the induction of class I antigen, content of ras gene products, the sorted sublines were very similar. We conclude that ras oncogene expression in these cells can influence the induction of class II antigen but that because ras expression in the sorted lines is similar the effect of ras expression is indirect and presumably involves interaction with other cellular factors.

摘要

当用 Kirsten 鼠肉瘤病毒转化时,C3H10T1/2 成纤维细胞在用γ干扰素(IFN-γ)诱导时失去了被诱导表达 II 类主要组织相容性复合体抗原的能力。在用 IFN-γ处理后通过细胞分选从转化细胞系中获得亚系,分选 H-2Ak 的低表达或高表达。这些亚系在分选后经过几代传代仍保持稳定的不可诱导或可诱导 II 类抗原的状态。在测试的所有其他方面,即对 IFN-γ产生抗病毒状态或诱导 I 类抗原的敏感性、ras 基因产物的含量,分选后的亚系非常相似。我们得出结论,这些细胞中 ras 癌基因的表达可以影响 II 类抗原的诱导,但由于分选细胞系中 ras 的表达相似,ras 表达的影响是间接的,大概涉及与其他细胞因子的相互作用。

相似文献

1
Interaction of v-Ki-ras oncogene and interferon-gamma in the control of histocompatibility antigen expression in mouse fibroblasts.v-Ki-ras癌基因与γ干扰素在小鼠成纤维细胞组织相容性抗原表达调控中的相互作用。
Cell Immunol. 1989 May;120(2):470-6. doi: 10.1016/0008-8749(89)90214-1.
2
Instability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformed by v-Ki-ras.表达活化的ras癌基因的成纤维细胞中主要组织相容性抗原表达的不稳定性:在一系列经v-Ki-ras转化的小鼠成纤维细胞克隆分离株中组成性及干扰素-γ诱导的I类和II类抗原
Br J Cancer. 1989 Aug;60(2):211-5. doi: 10.1038/bjc.1989.253.
3
Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras.γ干扰素对II类主要组织相容性复合体抗原的诱导作用与v-Ki-ras转化的C3H小鼠成纤维细胞的致瘤性降低有关。
J Exp Med. 1991 Jan 1;173(1):193-6. doi: 10.1084/jem.173.1.193.
4
Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line.柯斯顿鼠肉瘤病毒可消除鼠成纤维细胞系中γ干扰素诱导的Ⅱ类主要组织相容性抗原表达,但不影响Ⅰ类主要组织相容性抗原表达。
J Exp Med. 1988 Feb 1;167(2):706-11. doi: 10.1084/jem.167.2.706.
5
Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogene.由v-Ki-ras癌基因诱导的MHC抗原表达的顺序变化。
Cancer Immunol Immunother. 1993 Nov;37(6):361-6. doi: 10.1007/BF01526791.
6
Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. II. Effects on class II antigen expression.克尔斯滕小鼠肉瘤病毒和小鼠白血病病毒对干扰素-γ诱导的宿主细胞MHC抗原表达的调节。II. 对II类抗原表达的影响。
Immunology. 1989 May;67(1):26-31.
7
Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.v-Ki-ras转化细胞中的主要组织相容性复合体抗原:不同抗原的表达和诱导相互独立,且与抗病毒状态无关,由干扰素介导。
Immunology. 1990 Oct;71(2):224-9.
8
Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression.柯斯顿小鼠肉瘤病毒和小鼠白血病病毒对干扰素γ诱导的宿主细胞主要组织相容性复合体抗原表达的调节。I. 对I类抗原表达的影响。
Immunology. 1989 May;67(1):21-5.
9
Reduced stimulation of helper T cells by Ki-ras transformed cells.Ki-ras转化细胞对辅助性T细胞的刺激减少。
Immunology. 1991 Feb;72(2):277-81.
10
Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.经干扰素-γ处理的内皮细胞和成纤维细胞的抗原呈递:尽管Ia表达相当,但作为抗原呈递细胞发挥功能的能力存在差异。
J Immunol. 1985 Dec;135(6):3750-62.

引用本文的文献

1
Induction of intercellular adhesion molecule 1 and class II histocompatibility antigens in colorectal tumour cells expressing activated ras oncogene.在表达活化Ras癌基因的结肠直肠肿瘤细胞中诱导细胞间黏附分子1和II类组织相容性抗原。
Clin Mol Pathol. 1995 Dec;48(6):M326-32. doi: 10.1136/mp.48.6.m326.
2
Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.干扰素γ和视黄酸与转化生长因子β在免疫识别分子诱导过程中的相互作用。
Cancer Immunol Immunother. 1993 Jul;37(2):112-8. doi: 10.1007/BF01517043.
3
Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras.
γ干扰素对II类主要组织相容性复合体抗原的诱导作用与v-Ki-ras转化的C3H小鼠成纤维细胞的致瘤性降低有关。
J Exp Med. 1991 Jan 1;173(1):193-6. doi: 10.1084/jem.173.1.193.
4
Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.v-Ki-ras转化细胞中的主要组织相容性复合体抗原:不同抗原的表达和诱导相互独立,且与抗病毒状态无关,由干扰素介导。
Immunology. 1990 Oct;71(2):224-9.
5
The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells.作为肿瘤传代的ras转化鼠成纤维细胞II类主要组织相容性复合体(MHC)抗原表达的丧失与致瘤性增加相关,但不是由T细胞介导的。
Cancer Immunol Immunother. 1992;35(1):46-52. doi: 10.1007/BF01741054.